Warburg Research Analysts Give Draegerwerk AG & Co KGaA (ETR:DRW3) a €49.00 Price Target

Share on StockTwits

Warburg Research set a €49.00 ($56.98) price target on Draegerwerk AG & Co KGaA (ETR:DRW3) in a report issued on Tuesday morning, Borsen Zeitung reports. The firm currently has a neutral rating on the stock.

A number of other research analysts have also commented on the company. Hauck & Aufhaeuser set a €42.00 ($48.84) price target on Draegerwerk AG & Co KGaA and gave the stock a sell rating in a report on Monday, June 24th. Nord/LB set a €45.00 ($52.33) price objective on Draegerwerk AG & Co KGaA and gave the company a neutral rating in a research report on Friday, April 26th. HSBC restated a hold rating on shares of Anglo American in a research report on Tuesday, April 16th. Independent Research set a €45.00 ($52.33) price objective on Aurubis and gave the company a neutral rating in a research report on Monday, April 29th. Finally, Deutsche Bank set a €46.00 ($53.49) price objective on Draegerwerk AG & Co KGaA and gave the company a neutral rating in a research report on Tuesday, April 30th. Three analysts have rated the stock with a sell rating and four have assigned a hold rating to the company. The stock presently has a consensus rating of Hold and an average target price of €45.14 ($52.49).

Shares of DRW3 stock opened at €48.10 ($55.93) on Tuesday. Draegerwerk AG & Co KGaA has a 12 month low of €42.08 ($48.93) and a 12 month high of €73.00 ($84.88). The firm has a market capitalization of $365.56 million and a price-to-earnings ratio of 19.43. The stock’s 50 day simple moving average is €51.87. The company has a current ratio of 1.98, a quick ratio of 1.17 and a debt-to-equity ratio of 20.16.

About Draegerwerk AG & Co KGaA

Dr├Ągerwerk AG & Co KGaA develops equipment and solutions in the fields of medical and safety technology in Europe, Americas, Africa, Asia, and Australia. The company develops, produces, and markets system solutions, equipment, and services for acute point of care, including emergency care, perioperative care, critical care, and perinatal care.

Recommended Story: Short Selling Stocks and Day Traders

Analyst Recommendations for Draegerwerk AG & Co KGaA (ETR:DRW3)

Receive News & Ratings for Draegerwerk AG & Co KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Draegerwerk AG & Co KGaA and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.